PCI Pharma Services sell "Contained Potent Drug Manufacturing"

PCI has a long, proven track record manufacturing products that require specialized containment, with facilities capable of safely handling potent compounds down to an occupational exposure limit of 0.01 μg/m³. Ongoing investment in leading-edge engineering keeps the company at the forefront of the field, supporting a comprehensive service for solid-dose potent dosage forms.